You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Captopril; hydrochlorothiazide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for captopril; hydrochlorothiazide and what is the scope of patent protection?

Captopril; hydrochlorothiazide is the generic ingredient in five branded drugs marketed by Apothecon, Cosette, Ivax Sub Teva Pharms, Rising, Strides Pharma, and Watson Labs, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for captopril; hydrochlorothiazide
US Patents:0
Tradenames:5
Applicants:6
NDAs:6
Finished Product Suppliers / Packagers: 1
Clinical Trials: 4
DailyMed Link:captopril; hydrochlorothiazide at DailyMed
Recent Clinical Trials for captopril; hydrochlorothiazide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 1
West China HospitalPhase 4
Vanderbilt University Medical CenterPhase 1

See all captopril; hydrochlorothiazide clinical trials

Pharmacology for captopril; hydrochlorothiazide

US Patents and Regulatory Information for captopril; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074896-001 Dec 29, 1997 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Sub Teva Pharms CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 075055-003 Jun 18, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074896-004 Dec 29, 1997 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for captopril; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 ⤷  Sign Up ⤷  Sign Up
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 ⤷  Sign Up ⤷  Sign Up
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.